VSEE HEALTH, INC.

VSee Health, Inc. (NASDAQ:VSEE) (the "Company"), a provider of telehealth services and technology, announced that it has identified approximately $1 million in near term annual savings associated with its transition from Nasdaq, the reduction of public-company expenses and the streamlining of its corporate operations. The Company intends to redirect these savings toward revenue-generating growth initiatives, working capital and the continued expansion of its hospital-based telehealth operations.Although the Company's delisting from Nasdaq was disappointing, management believes the transition provides VSee with an important opportunity to right size its cost structure and focus a greater percentage of its resources on growing revenue, improving collections and supporting its core healthcare operations.Key Annual Meeting ResultsReverse Split of 80:1WWC as auditors2 BOD members were renewedHospital Expansion and Improved CollectionsThe Company currently has a several new hospitals scheduled to come online and is working to accelerate their implementation and contribution to revenue.VSee has also identified and begun implementing measures intended to increase the collection of approximately $8 million of recently billed healthcare accounts receivable. Management believes that improving collections and overall revenue-cycle management can provide additional working capital to support the Company's operations and growth.The Company's principal objectives include:Bringing newly contracted hospitals online and accelerating revenue generation;Redirecting approximately $1 million in anticipated annual savings toward growth and operating initiatives;Improving billing, collections and overall revenue-cycle management;Rightsizing the Company's corporate and operating cost structure;Strengthening working capital while minimizing unnecessary stockholder dilution; andBuilding a more focused, efficient and sustainable healthcare-services business.Planned New Corporate IdentityAs previously announced, the Company will continue to explore areas of growth organically and through M&A activity. As part of this broader repositioning, the Company also intends to move forward with adopting a new corporate name that more accurately reflects its focused operating business, future direction and commitment to hospital-based healthcare services.Management believes the new identity will mark a fresh chapter for the Company. The proposed name and anticipated timing will be announced following completion of the required Board, stockholder and regulatory approvals."While we were disappointed by the Nasdaq delisting, we are genuinely excited about the opportunity now in front of us," said Imo Aisiku, M.D., Chief Executive Officer of VSee Health. "We have taken a hard look at every area of the business and identified meaningful savings that can now be invested directly into opportunities that generate revenue and help support our customers."With additional hospitals coming online, approximately $8 million of recently billed receivables, a substantially more efficient operating structure and a new corporate identity planned, we believe the Company is entering its next chapter with greater focus, improving momentum and a clear path forward. This is an opportunity to give the business a fresh start, and our entire team is energized and optimistic about what we can accomplish for our customers and stockholders."About VSee Health, Inc. (NASDAQ:VSEE)VSee Health is a leader in Telehealth technology, providing configurable virtual care solutions-including secure video, remote monitoring, Enhanced workflows, and seamless EHR integrations-for health systems, government agencies, and large enterprises. Through its iDo

VSee Health, Inc. (NASDAQ:VSEE) (the "Company"), a provider of telehealth services and technology, announced that it has identified approximately $1 million in near term annual savings associated with its transition from Nasdaq, the reduction of public-company expenses and the streamlining of its corporate operations. The Company intends to redirect these savings toward revenue-generating growth initiatives, working capital and the continued expansion of its hospital-based telehealth operations.Although the Company's delisting from Nasdaq was disappointing, management believes the transition provides VSee with an important opportunity to right size its cost structure and focus a greater percentage of its resources on growing revenue, improving collections and supporting its core healthcare operations.Key Annual Meeting ResultsReverse Split of 80:1WWC as auditors2 BOD members were renewedHospital Expansion and Improved CollectionsThe Company currently has a several new hospitals scheduled to come online and is working to accelerate their implementation and contribution to revenue.VSee has also identified and begun implementing measures intended to increase the collection of approximately $8 million of recently billed healthcare accounts receivable. Management believes that improving collections and overall revenue-cycle management can provide additional working capital to support the Company's operations and growth.The Company's principal objectives include:Bringing newly contracted hospitals online and accelerating revenue generation;Redirecting approximately $1 million in anticipated annual savings toward growth and operating initiatives;Improving billing, collections and overall revenue-cycle management;Rightsizing the Company's corporate and operating cost structure;Strengthening working capital while minimizing unnecessary stockholder dilution; andBuilding a more focused, efficient and sustainable healthcare-services business.Planned New Corporate IdentityAs previously announced, the Company will continue to explore areas of growth organically and through M&A activity. As part of this broader repositioning, the Company also intends to move forward with adopting a new corporate name that more accurately reflects its focused operating business, future direction and commitment to hospital-based healthcare services.Management believes the new identity will mark a fresh chapter for the Company. The proposed name and anticipated timing will be announced following completion of the required Board, stockholder and regulatory approvals."While we were disappointed by the Nasdaq delisting, we are genuinely excited about the opportunity now in front of us," said Imo Aisiku, M.D., Chief Executive Officer of VSee Health. "We have taken a hard look at every area of the business and identified meaningful savings that can now be invested directly into opportunities that generate revenue and help support our customers."With additional hospitals coming online, approximately $8 million of recently billed receivables, a substantially more efficient operating structure and a new corporate identity planned, we believe the Company is entering its next chapter with greater focus, improving momentum and a clear path forward. This is an opportunity to give the business a fresh start, and our entire team is energized and optimistic about what we can accomplish for our customers and stockholders."About VSee Health, Inc. (NASDAQ:VSEE)VSee Health is a leader in Telehealth technology, providing configurable virtual care solutions-including secure video, remote monitoring, Enhanced workflows, and seamless EHR integrations-for health systems, government agencies, and large enterprises. Through its iDo

VSee Health, Inc. (NASDAQ:VSEE) ("VSee" or the "Company"), a leading provider of telehealth technology and digital health solutions, today announced that it has entered into a non-binding letter of intent (the "LOI") for the proposed acquisition of certain healthcare technology and operating assets. The contemplated assets support an integrated healthcare commerce platform serving the United States clinic-based wellness market. The current annual run rate for the target assets is in excess of $35 million, and EBITDA is approximately $7 million (both figures are unaudited).The highly profitable proposed acquisition would bring together complementary capabilities across provider-facing sales and account management, cloud-based ordering and payment workflows, and supplier coordination and back-office operations. The platform is designed to connect suppliers, commercial organizations and clinics through an integrated operating model spanning customer development, digital commerce and order reconciliation. Consistent with an asset-light approach, the platform coordinates these workflows while suppliers and other regulated parties retain their respective product and fulfillment responsibilities.VSee believes these capabilities could complement its existing API-driven virtual care platform and broaden the digital infrastructure it can offer to healthcare organizations. The contemplated transaction is one of the strategic opportunities being evaluated as part of the Company's previously announced strategic review, which is focused on accelerating growth, strengthening VSee's competitive position and creating long-term stockholder value."We believe VSee is entering a defining chapter in the Company's evolution," said Imo Aisiku, Chief Executive Officer of VSee Health.Our objective is not simply to complete acquisitions, but to build a larger, stronger and better-capitalized healthcare technology company with multiple engines of growth. This LOI is one example of that strategy in action. We are actively advancing additional strategic initiatives that have the potential to significantly enhance our capital resources, expand our operating platform and accelerate long-term growth. We believe the momentum we are building has the potential to reshape the future of VSee and create meaningful, sustainable value for our stockholders.VSee will continue its evaluation of the proposed acquisition with customary due diligence and the preparation and negotiation of definitive documentation. The LOI is non-binding, except for certain customary provisions. Any transaction remains subject to the completion of due diligence, negotiation and execution of definitive agreements, applicable corporate, stockholder, regulatory and stock exchange approvals, as applicable, and other customary closing conditions. There can be no assurance that definitive agreements will be executed or that the proposed transaction will be completed. The Company does not expect to provide additional updates until definitive agreements are signed, or further disclosure is deemed appropriate.About VSee Health, Inc.VSee Health (NASDAQ:VSEE) provides telehealth technology and digital health solutions through a scalable, API-driven platform. VSee's offerings support high-acuity virtual care and combine secure video, remote patient monitoring, connected devices and electronic health record integration for hospitals, health systems, clinicians and enterprise healthcare organizations in the United States.Forward-Looking StatementsThis press release includes forward-looking statements within the meaning of the federal securities laws. These statements include, among other things, expectations regarding the proposed asset acquisition, the parties' ability to complete diligence and negotiate definitive documentation, potential benefits of the contemplated transaction, the Company's strategic review, growth prospects and creat

VSee Health, Inc. (NASDAQ:VSEE) ("VSee" or the "Company"), a leading provider of telehealth technology and digital health solutions, today announced that it has entered into a non-binding letter of intent (the "LOI") for the proposed acquisition of certain healthcare technology and operating assets. The contemplated assets support an integrated healthcare commerce platform serving the United States clinic-based wellness market. The current annual run rate for the target assets is in excess of $35 million, and EBITDA is approximately $7 million (both figures are unaudited).The highly profitable proposed acquisition would bring together complementary capabilities across provider-facing sales and account management, cloud-based ordering and payment workflows, and supplier coordination and back-office operations. The platform is designed to connect suppliers, commercial organizations and clinics through an integrated operating model spanning customer development, digital commerce and order reconciliation. Consistent with an asset-light approach, the platform coordinates these workflows while suppliers and other regulated parties retain their respective product and fulfillment responsibilities.VSee believes these capabilities could complement its existing API-driven virtual care platform and broaden the digital infrastructure it can offer to healthcare organizations. The contemplated transaction is one of the strategic opportunities being evaluated as part of the Company's previously announced strategic review, which is focused on accelerating growth, strengthening VSee's competitive position and creating long-term stockholder value."We believe VSee is entering a defining chapter in the Company's evolution," said Imo Aisiku, Chief Executive Officer of VSee Health.Our objective is not simply to complete acquisitions, but to build a larger, stronger and better-capitalized healthcare technology company with multiple engines of growth. This LOI is one example of that strategy in action. We are actively advancing additional strategic initiatives that have the potential to significantly enhance our capital resources, expand our operating platform and accelerate long-term growth. We believe the momentum we are building has the potential to reshape the future of VSee and create meaningful, sustainable value for our stockholders.VSee will continue its evaluation of the proposed acquisition with customary due diligence and the preparation and negotiation of definitive documentation. The LOI is non-binding, except for certain customary provisions. Any transaction remains subject to the completion of due diligence, negotiation and execution of definitive agreements, applicable corporate, stockholder, regulatory and stock exchange approvals, as applicable, and other customary closing conditions. There can be no assurance that definitive agreements will be executed or that the proposed transaction will be completed. The Company does not expect to provide additional updates until definitive agreements are signed, or further disclosure is deemed appropriate.About VSee Health, Inc.VSee Health (NASDAQ:VSEE) provides telehealth technology and digital health solutions through a scalable, API-driven platform. VSee's offerings support high-acuity virtual care and combine secure video, remote patient monitoring, connected devices and electronic health record integration for hospitals, health systems, clinicians and enterprise healthcare organizations in the United States.Forward-Looking StatementsThis press release includes forward-looking statements within the meaning of the federal securities laws. These statements include, among other things, expectations regarding the proposed asset acquisition, the parties' ability to complete diligence and negotiate definitive documentation, potential benefits of the contemplated transaction, the Company's strategic review, growth prospects and creat

VSee Health, Inc. (NASDAQ:VSEE) ("VSee" or the "Company"), a leading provider of telehealth technology and digital health solutions, today announced that it has entered into a non-binding letter of intent (the "LOI") for the proposed acquisition of certain healthcare technology and operating assets. The contemplated assets support an integrated healthcare commerce platform serving the United States clinic-based wellness market. The current annual run rate for the target assets is in excess of $35 million, and EBITDA is approximately $7 million (both figures are unaudited).The highly profitable proposed acquisition would bring together complementary capabilities across provider-facing sales and account management, cloud-based ordering and payment workflows, and supplier coordination and back-office operations. The platform is designed to connect suppliers, commercial organizations and clinics through an integrated operating model spanning customer development, digital commerce and order reconciliation. Consistent with an asset-light approach, the platform coordinates these workflows while suppliers and other regulated parties retain their respective product and fulfillment responsibilities.VSee believes these capabilities could complement its existing API-driven virtual care platform and broaden the digital infrastructure it can offer to healthcare organizations. The contemplated transaction is one of the strategic opportunities being evaluated as part of the Company's previously announced strategic review, which is focused on accelerating growth, strengthening VSee's competitive position and creating long-term stockholder value."We believe VSee is entering a defining chapter in the Company's evolution," said Imo Aisiku, Chief Executive Officer of VSee Health. "Our objective is not simply to complete acquisitions, but to build a larger, stronger and better-capitalized healthcare technology company with multiple engines of growth. This LOI is one example of that strategy in action. We are actively advancing additional strategic initiatives that have the potential to significantly enhance our capital resources, expand our operating platform and accelerate long-term growth. We believe the momentum we are building has the potential to reshape the future of VSee and create meaningful, sustainable value for our stockholders."VSee will continue its evaluation of the proposed acquisition with customary due diligence and the preparation and negotiation of definitive documentation. The LOI is non-binding, except for certain customary provisions. Any transaction remains subject to the completion of due diligence, negotiation and execution of definitive agreements, applicable corporate, stockholder, regulatory and stock exchange approvals, as applicable, and other customary closing conditions. There can be no assurance that definitive agreements will be executed or that the proposed transaction will be completed. The Company does not expect to provide additional updates until definitive agreements are signed, or further disclosure is deemed appropriate.About VSee Health, Inc.VSee Health (NASDAQ:VSEE) provides telehealth technology and digital health solutions through a scalable, API-driven platform. VSee's offerings support high-acuity virtual care and combine secure video, remote patient monitoring, connected devices and electronic health record integration for hospitals, health systems, clinicians and enterprise healthcare organizations in the United States.Forward-Looking StatementsThis press release includes forward-looking statements within the meaning of the federal securities laws. These statements include, among other things, expectations regarding the proposed asset acquisition, the parties' ability to complete diligence and negotiate definitive documentation, potential benefits of the contemplated transaction, the Company's strategic revi

VSee Health, Inc. (NASDAQ:VSEE) ("VSee" or the "Company"), a leading provider of telehealth technology and digital health solutions, today announced that it has entered into a non-binding letter of intent (the "LOI") for the proposed acquisition of certain healthcare technology and operating assets. The contemplated assets support an integrated healthcare commerce platform serving the United States clinic-based wellness market. The current annual run rate for the target assets is in excess of $35 million, and EBITDA is approximately $7 million (both figures are unaudited).The highly profitable proposed acquisition would bring together complementary capabilities across provider-facing sales and account management, cloud-based ordering and payment workflows, and supplier coordination and back-office operations. The platform is designed to connect suppliers, commercial organizations and clinics through an integrated operating model spanning customer development, digital commerce and order reconciliation. Consistent with an asset-light approach, the platform coordinates these workflows while suppliers and other regulated parties retain their respective product and fulfillment responsibilities.VSee believes these capabilities could complement its existing API-driven virtual care platform and broaden the digital infrastructure it can offer to healthcare organizations. The contemplated transaction is one of the strategic opportunities being evaluated as part of the Company's previously announced strategic review, which is focused on accelerating growth, strengthening VSee's competitive position and creating long-term stockholder value."We believe VSee is entering a defining chapter in the Company's evolution," said Imo Aisiku, Chief Executive Officer of VSee Health. "Our objective is not simply to complete acquisitions, but to build a larger, stronger and better-capitalized healthcare technology company with multiple engines of growth. This LOI is one example of that strategy in action. We are actively advancing additional strategic initiatives that have the potential to significantly enhance our capital resources, expand our operating platform and accelerate long-term growth. We believe the momentum we are building has the potential to reshape the future of VSee and create meaningful, sustainable value for our stockholders."VSee will continue its evaluation of the proposed acquisition with customary due diligence and the preparation and negotiation of definitive documentation. The LOI is non-binding, except for certain customary provisions. Any transaction remains subject to the completion of due diligence, negotiation and execution of definitive agreements, applicable corporate, stockholder, regulatory and stock exchange approvals, as applicable, and other customary closing conditions. There can be no assurance that definitive agreements will be executed or that the proposed transaction will be completed. The Company does not expect to provide additional updates until definitive agreements are signed, or further disclosure is deemed appropriate.About VSee Health, Inc.VSee Health (NASDAQ:VSEE) provides telehealth technology and digital health solutions through a scalable, API-driven platform. VSee's offerings support high-acuity virtual care and combine secure video, remote patient monitoring, connected devices and electronic health record integration for hospitals, health systems, clinicians and enterprise healthcare organizations in the United States.Forward-Looking StatementsThis press release includes forward-looking statements within the meaning of the federal securities laws. These statements include, among other things, expectations regarding the proposed asset acquisition, the parties' ability to complete diligence and negotiate definitive documentation, potential benefits of the contemplated transaction, the Company's strategic revi

VSee Health, Inc. (NASDAQ:VSEE) ("VSee" or the "Company"), a leading provider of telehealth and digital health solutions, today announced that its Board of Directors has initiated a comprehensive strategic review aimed at pursuing transformational opportunities to accelerate growth and maximize shareholder value.The Board believes VSee has reached an important inflection point. Over the past year, the Company has strengthened its operating foundation, enhanced its technology platform and continued to expand its position in the rapidly evolving digital healthcare market. As a result, the Board believes this is the appropriate time to evaluate strategic opportunities that can accelerate growth and unlock the full value of the business.The Company is actively engaged in late-stage discussions with potential strategic partners and is pursuing these opportunities with urgency and an aggressive timeline. The Board is evaluating a broad range of strategic alternatives, with the objective of executing the strategic alternative that it believes has the greatest potential to maximize long-term shareholder value.Potential strategic alternatives under consideration may include strategic partnerships, business combinations, mergers, acquisitions, licensing transactions, capital formation initiatives and other strategic opportunities designed to strengthen the Company's competitive position and accelerate long-term growth."VSee has built a differentiated virtual care platform with meaningful customer relationships and significant long-term growth potential," said Imo Aisiku, Chief Executive Officer of VSee Health. "We believe our current market valuation does not fully reflect the strength of our technology, our business or the opportunities ahead. Our Board is focused on pursuing the strategic alternative that creates the greatest long-term value for our shareholders while continuing to execute our business strategy and deliver exceptional service to our customers."The strategic review is being conducted under the direction of the Company's Board of Directors. There can be no assurance that the strategic review process will result in the completion of any transaction or other strategic outcome, or as to the timing or terms of any such transaction. The Company does not intend to comment further regarding the strategic review unless and until its Board of Directors approves a specific transaction or determines that additional disclosure is appropriate or required by applicable law.About VSee Health, Inc.VSee Health (NASDAQ:VSEE) is a leading provider of telehealth technology and digital health solutions, delivering high-acuity virtual care through its scalable, API-driven platform. The Company's solutions integrate secure video, remote patient monitoring, device connectivity and electronic health record integration to support hospitals, health systems, providers and enterprise healthcare organizations across the United States.Forward-Looking StatementsThis press release contains forward-looking statements within the meaning of the federal securities laws, including statements regarding the Company's strategic review process, potential strategic transactions, future growth opportunities and shareholder value. These forward-looking statements are based on current expectations and assumptions and involve risks and uncertainties that could cause actual results to differ materially from those anticipated. Readers are encouraged to review the Company's filings with the U.S. Securities and Exchange Commission, including its most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q for a discussion of these and other risk factors. VSee undertakes no obligation to update any forward-looking statements except as required by applicable law.Investors Contact:Justin Smith<a href="mailto:jsmith@idocvms.com

VSee Health, Inc. (NASDAQ:VSEE) ("VSee" or the "Company"), a leading provider of telehealth and digital health solutions, today announced that its Board of Directors has initiated a comprehensive strategic review aimed at pursuing transformational opportunities to accelerate growth and maximize shareholder value.The Board believes VSee has reached an important inflection point. Over the past year, the Company has strengthened its operating foundation, enhanced its technology platform and continued to expand its position in the rapidly evolving digital healthcare market. As a result, the Board believes this is the appropriate time to evaluate strategic opportunities that can accelerate growth and unlock the full value of the business.The Company is actively engaged in late-stage discussions with potential strategic partners and is pursuing these opportunities with urgency and an aggressive timeline. The Board is evaluating a broad range of strategic alternatives, with the objective of executing the strategic alternative that it believes has the greatest potential to maximize long-term shareholder value.Potential strategic alternatives under consideration may include strategic partnerships, business combinations, mergers, acquisitions, licensing transactions, capital formation initiatives and other strategic opportunities designed to strengthen the Company's competitive position and accelerate long-term growth."VSee has built a differentiated virtual care platform with meaningful customer relationships and significant long-term growth potential," said Imo Aisiku, Chief Executive Officer of VSee Health. "We believe our current market valuation does not fully reflect the strength of our technology, our business or the opportunities ahead. Our Board is focused on pursuing the strategic alternative that creates the greatest long-term value for our shareholders while continuing to execute our business strategy and deliver exceptional service to our customers."The strategic review is being conducted under the direction of the Company's Board of Directors. There can be no assurance that the strategic review process will result in the completion of any transaction or other strategic outcome, or as to the timing or terms of any such transaction. The Company does not intend to comment further regarding the strategic review unless and until its Board of Directors approves a specific transaction or determines that additional disclosure is appropriate or required by applicable law.About VSee Health, Inc.VSee Health (NASDAQ:VSEE) is a leading provider of telehealth technology and digital health solutions, delivering high-acuity virtual care through its scalable, API-driven platform. The Company's solutions integrate secure video, remote patient monitoring, device connectivity and electronic health record integration to support hospitals, health systems, providers and enterprise healthcare organizations across the United States.Forward-Looking StatementsThis press release contains forward-looking statements within the meaning of the federal securities laws, including statements regarding the Company's strategic review process, potential strategic transactions, future growth opportunities and shareholder value. These forward-looking statements are based on current expectations and assumptions and involve risks and uncertainties that could cause actual results to differ materially from those anticipated. Readers are encouraged to review the Company's filings with the U.S. Securities and Exchange Commission, including its most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q for a discussion of these and other risk factors. VSee undertakes no obligation to update any forward-looking statements except as required by applicable law.Investors Contact:Justin Smith<a href="mailto:jsmith@idocvms.com

VSee Health, Inc. (NASDAQ:VSEE) ("VSee" or the "Company"), a leading provider of telehealth and digital health solutions, today reaffirmed its commitment to protecting shareholder value by minimizing dilution while maintaining the financial flexibility needed to execute its growth strategy. Our Board of Directors has approved a proposed maximum of an 80-for-1 reverse stock split, subject to the completion of all applicable regulatory requirements and shareholder approvals. This action is intended to better align our capital structure with our long-term strategic objectives and support our continued Nasdaq listing. The company wants to affirm with its shareholders, the upcoming reverse split has been corrected from max of up to 250 to no more than 80 to 1.The Company confirmed that it has terminated the previously announced standby equity purchase agreement. VSee currently has no active equity financing facility expected to result in near-term dilution.As of July 6, 2026, the Company had 55,679,813 shares of common stock outstanding. Over the past 45 days, VSee has strengthened its balance sheet through non-dilutive financing and avoiding the use of any standby equity facility.VSee Health Chairman and Chief Executive Officer Dr. Imoigele Aisiku commented:"Our goal is to minimize shareholder dilution while strengthening our balance sheet and investing in the continued growth of our business. We believe our recent financing activities, together with the termination of the standby equity purchase agreement, provide us with the flexibility to execute our strategy while protecting long-term shareholder value."Dr. Aisiku continued:"We have also taken the necessary steps to maintain our Nasdaq listing by asking shareholders to consider a potential reverse stock split at our upcoming Annual Meeting. If approved, the Board intends to implement the lowest reverse split ratio necessary to satisfy Nasdaq's continued listing requirements while preserving shareholder value."About VSee Health, Inc.VSee Health (NASDAQ:VSEE) is a telehealth technology and services company delivering high-acuity virtual care solutions through its scalable, API-driven platform. The Company's offerings integrate secure video, device data, and EHR connectivity to power hospital systems, health networks, and employers across the United States.For more information, please visit our website: https://www.idocvms.comForward-Looking StatementsThis press release contains certain statements that may be deemed to be forward-looking statements within the meaning of the federal securities laws, including the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Such statements may be preceded by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential," or similar words or the negative of these terms or other similar expressions, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements are not guarantees of future performance, are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the control of VSee Health, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. More detailed information about VSee Health and the risk factors that may affect the realization of forward-looking statements is set forth in the filings with the Securities and Exchange Commission ("SEC"), including the most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC's we

VSee Health, Inc. (NASDAQ:VSEE) ("VSee" or the "Company"), a leading provider of telehealth and digital health solutions, today reaffirmed its commitment to protecting shareholder value by minimizing dilution while maintaining the financial flexibility needed to execute its growth strategy. Our Board of Directors has approved a proposed maximum of an 80-for-1 reverse stock split, subject to the completion of all applicable regulatory requirements and shareholder approvals. This action is intended to better align our capital structure with our long-term strategic objectives and support our continued Nasdaq listing. The company wants to affirm with its shareholders, the upcoming reverse split has been corrected from max of up to 250 to no more than 80 to 1.The Company confirmed that it has terminated the previously announced standby equity purchase agreement. VSee currently has no active equity financing facility expected to result in near-term dilution.As of July 6, 2026, the Company had 55,679,813 shares of common stock outstanding. Over the past 45 days, VSee has strengthened its balance sheet through non-dilutive financing and avoiding the use of any standby equity facility.VSee Health Chairman and Chief Executive Officer Dr. Imoigele Aisiku commented:"Our goal is to minimize shareholder dilution while strengthening our balance sheet and investing in the continued growth of our business. We believe our recent financing activities, together with the termination of the standby equity purchase agreement, provide us with the flexibility to execute our strategy while protecting long-term shareholder value."Dr. Aisiku continued:"We have also taken the necessary steps to maintain our Nasdaq listing by asking shareholders to consider a potential reverse stock split at our upcoming Annual Meeting. If approved, the Board intends to implement the lowest reverse split ratio necessary to satisfy Nasdaq's continued listing requirements while preserving shareholder value."About VSee Health, Inc.VSee Health (NASDAQ:VSEE) is a telehealth technology and services company delivering high-acuity virtual care solutions through its scalable, API-driven platform. The Company's offerings integrate secure video, device data, and EHR connectivity to power hospital systems, health networks, and employers across the United States.For more information, please visit our website: https://www.idocvms.comForward-Looking StatementsThis press release contains certain statements that may be deemed to be forward-looking statements within the meaning of the federal securities laws, including the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Such statements may be preceded by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential," or similar words or the negative of these terms or other similar expressions, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements are not guarantees of future performance, are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the control of VSee Health, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. More detailed information about VSee Health and the risk factors that may affect the realization of forward-looking statements is set forth in the filings with the Securities and Exchange Commission ("SEC"), including the most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC's we